Senior Scientist of Translational Science RIA IM

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines for some of the world?s most serious diseases. But we're more than one of the world's leading pharmaceutical companies. At AstraZeneca, we're proud to have a unique workplace culture that inspires innovation and collaboration. Here, employees are empowered to express diverse perspectives - and are made to feel valued, energized and rewarded for their ideas and creativity.

The Role
We are currently looking for innovative and highly motivated scientists to join the Translational Science Team within the Respiratory, Inflammation and Autoimmunity Innovative Medicine Unit in Mölndal / Göteborg, Sweden. Successful candidates will become part of a newly formed, creative and flexible team that identifies new targets in human respiratory and autoimmune diseases based on the deep understanding the driving disease mechanisms. We are interested in scientists with a strong background in immunology and with a proven track record of research in academia or industry. In the role you will combine your creative ideas with the hands-on scientific research activities. We are looking for expertise in a range of immunological and molecular biology methods needed for the driving in-house translational research.

Key Duties and Responsibilities
- You will drive discovery research activities to build the scientific knowledge in the disease areas.
- You will deliver new target ideas and validate those in relevant in vitro and vivo models.
- You will develop biomarkers suitable for disease phenotyping and patient segmentation.
- Good team playing and communication skills and ability to operate effectively in a multidisciplinary research environment.
- Communicating results within AstraZeneca and externally at meetings and publications.

Education:
PhD

Experience:
Approx three years post doctoral training
A strong record of published research in immunology or in respiratory and inflammatory diseases

Welcome with your application, ref no MOL000001N5, via www.astrazeneca.se no later than March 16, 2015.